Covered recipient · General Payments record
PIERRE P MANFROY
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2019–2025
$2,203.83
- Reported across 126 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.10 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $84.35 | 4 |
| SANOFI-AVENTIS U.S. LLC | $37.06 | 2 |
| Corium, Inc. | $32.72 | 2 |
| Merck Sharp & Dohme Corporation | $23.30 | 1 |
| Soleno Therapeutics, Inc. | $21.31 | 1 |
| Novo Nordisk AS | $18.38 | 1 |
| Collegium Pharmaceutical, Inc. | $16.25 | 1 |
| Neos Therapeutics, LP | $14.98 | 1 |
| GlaxoSmithKline, LLC. | $14.10 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $16.25 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224186778 | CMS |
| Corium, LLC | $17.22 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1185803438 | CMS |
| Corium, LLC | $15.50 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1185797950 | CMS |
| GlaxoSmithKline, LLC. | $14.10 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190693050 | CMS |
| Merck Sharp & Dohme LLC | $23.30 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238085387 | CMS |
| Neos Therapeutics, LP | $14.98 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206090197 | CMS |
| Novo Nordisk Inc | $18.38 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188749574 | CMS |
| PFIZER INC. | $16.90 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231107502 | CMS |
| PFIZER INC. | $22.23 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231243722 | CMS |
| PFIZER INC. | $22.73 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231309843 | CMS |
| PFIZER INC. | $22.49 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229422685 | CMS |
| SANOFI-AVENTIS U.S. LLC | $20.97 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233327320 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.09 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233327356 | CMS |
| Soleno Therapeutics, Inc. | $21.31 | 08/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241820711 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.65 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244872392 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.